Back to Results
First PageMeta Content
Health / Environmental issues / Genetic engineering / Influenza vaccine / Genetically modified organism / Biotechnology / Soybean / Genetically modified food / Chiron Corporation / Biology / Vaccines / Medicine


Biopress selection 9 December 2005
Add to Reading List

Document Date: 2006-05-08 10:17:22


Open Document

File Size: 22,33 KB

Share Result on Facebook

City

Agra / Paris / /

Company

Novartis / Chiron / GMOs (Europe 2/12/05) Pharma / New York Times / GM / /

Continent

Asia / Europe / /

Country

Germany / Cyprus / Sweden / France / Japan / United States / Uganda / Vietnam / United Kingdom / China / /

Currency

GBP / /

Event

M&A / /

IndustryTerm

cancer treatment / genetic engineering law / food / plastics / allergy treatment / high-tech industry / /

MedicalCondition

celiac disease / HIV / flu / health Cancer / zoonoses / wildlife disease / AIDS epidemic / Long Island breast cancer / HIV epidemic / Obesity / spinal injury / infections / Animal diseases / Friedreich’s Ataxia / Pancreatic cancer / fatal diseases / Parasitic diseases / health Food allergy / Cancer / Ebola / Healthcare Infectious / universal flu / sickness / allergy / childhood cancer / mastitis / Sexually transmitted infections / AIDS / flu virus / human bird flu / neurodegenerative diseases / breast and prostate cancer / Genetic disorders / tumours / /

MedicalTreatment

vaccination / /

Organization

OECD / Global Fund / Environment Council / Greenpeace / European Federation of Regenerative Medicine / Food safety / European Union / /

Person

Healthcare Cancer / /

Position

Economist / researcher / Scientist / /

Product

Global Fund suspension / /

PublishedMedium

New Scientist / Guardian / Proteomics / New York Times / Nature Medicine / Le Soir / /

Region

South Africa / /

Technology

Genomics / Proteomics / genetic engineering / stem cells / drug discovery / Tissue engineering / biofuels / bioprocessing / drug development / Regenerative Medicine / /

SocialTag